CLINICAL_TRIALS
trial_result
· 2014-05-08
Clinical Trial Update: Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes [Phase 3]
Summary
Phase 3 efficacy and safety results for MP-513 in combination with a sulfonylurea in adults with Type 2 Diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-05-08